News & events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

OncoArendi Therapeutics has signed an exclusive agreement

30 January 2014

OncoArendi Therapeutics has closed its angel investment round raising

21 January 2014

OncoArendi has signed a contract agreement with the Polish Agency for Enterprise Development

5 November 2013

The Nencki Institute of Experimental Biology has just signed

6 June 2013

A patent application for the OAT-449

9 April 2013

Funding received for the first discovery program

7 September 2012

Events & Presentations

R&D Day Presentation, 07.12.2022

7 December 2022

Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches – February 19-23, 2020 | Victoria, BC, Canada

27 February 2020

EFMC-ASMC’19 – September 1-5, 2019 | Athens, Greece

11 September 2019

ACS National Meeting & Expo – August 25 – 29, 2019 | San Diego, CA

4 September 2019

ATS- International Conference – Dallas, 17-22.05.2019

22 May 2019

EFMC – YMCS – Young Medicinal Chemist Symposium – Ljubljana 02-06.09.2018

17 September 2018
This site is registered on wpml.org as a development site.